Investment Rating - The report maintains a "Positive" outlook for the defense and military industry [4] Core Insights - The focus is on increasing allocations in the large aircraft and military trade sectors, with expectations for growth in these areas due to geopolitical events and advancements in core technologies [8] - The large aircraft sector is expected to see accelerated development, particularly with the C919 aircraft, as key components are set to achieve certification and production targets [11][12] - Military trade is anticipated to benefit from heightened defense spending in the Middle East due to regional tensions, with expectations for increased market share for Chinese military exports [12] - The commercial aerospace sector is viewed positively for the first half of the year, despite recent adjustments and lower-than-expected launch activities [13] - Domestic demand in the military sector is expected to recover, with potential for exceeding current market pessimism as the "14th Five-Year Plan" progresses [14] Summary by Sections 1.1 Large Aircraft - The report highlights that the current market has low expectations for the large aircraft sector, particularly regarding the C919's delivery volumes. However, advancements in engine and onboard systems are expected to accelerate, potentially leading to a faster-than-expected development pace in the next two years [11][12] 1.2 Military Trade - The report notes that escalating tensions in the Middle East are likely to increase defense spending and military imports in the region. China's military trade share is expected to rise as countries diversify their defense procurement sources [12] 1.3 Commercial Aerospace - Despite recent adjustments in the commercial aerospace sector, the report maintains a positive outlook for investment opportunities in leading companies, particularly in satellite manufacturing and related technologies [13] 1.4 Domestic Military Demand - The report suggests that the market has been overly pessimistic regarding domestic demand recovery. It anticipates that as geopolitical uncertainties rise and the "14th Five-Year Plan" is implemented, demand in the military sector may recover faster than expected [14] 1.5 Investment Recommendations - The report recommends actively investing in core targets within the large aircraft and military trade sectors, while monitoring the commercial aerospace sector for potential catalysts. Specific companies are highlighted for investment consideration [16]

（文章来源：证券日报） 证券日报网讯 2月13日，华秦科技发布公告称，公司2025年实现营业收入125121.97万元，同比增长 9.83%；归属于母公司所有者的净利润31343.58万元。 ...

Core Viewpoint - The news summarizes important announcements from various companies, highlighting significant developments in their operations and financial performance. Company Announcements - Tianfeng Securities received a notice from the China Securities Regulatory Commission regarding a case of information disclosure violation related to Fujian Yong'an Forestry Group, and the company will cooperate with the investigation [3] - Southwest Securities plans to raise no more than 6 billion yuan through a private placement to supplement its capital and optimize its capital structure [4] - Qiaoyin Co. has terminated its investment in the artificial intelligence industry headquarters project due to changes in cooperation conditions, with a planned investment of no more than 1 billion yuan [5] - Zongshen Power is planning a major asset swap with Longxin General, aiming to resolve competition issues and promote clearer business development [6] - Laimei Pharmaceutical's selected products for national centralized procurement are expected to generate 106 million yuan in sales for 2024, accounting for 13.35% of the company's revenue [7] Performance Reports - Huayin Technology reported a net profit of 313 million yuan for 2025, a decrease of 24.28%, with revenue of 1.251 billion yuan, up 9.83% [9] - Youlide announced a net profit of 152 million yuan for 2025, down 16.88%, with revenue of 1.221 billion yuan, up 7.99% [10][11] - Fudan Microelectronics reported a net profit of 232 million yuan for 2025, a decline of 59.42%, with revenue of 3.982 billion yuan, up 10.92% [12] - Hanzhong Precision reported a net profit of 470 million yuan for 2025, down 45.54%, with revenue of 2.928 billion yuan, a decrease of 20.32% [13] Shareholding Changes - Gaomei Co.'s controlling shareholder and several directors plan to reduce their holdings by up to 3.19% of the company's shares [15] - Guanghuan New Network's controlling shareholder intends to reduce its stake by up to 3% [16] - ST Yigou's shareholder plans to reduce its holdings by up to 2.5% [17] - Juguang Technology's shareholders plan to collectively reduce their holdings by up to 2.3339% [18] - Xiandai Jidian's shareholder intends to reduce its stake by up to 2.05% [19] - Zhejing Pharmaceutical's shareholders plan to reduce their holdings by up to 1.0385% [21] Contract Signings - China Nuclear Construction signed contracts worth 3.393 billion yuan in January, with total revenue of 7.69 billion yuan [23] - China Chemical signed contracts totaling 36.925 billion yuan in January, including significant contracts over 500 million yuan [24]

Group 1 - RuiLian New Materials reported a total operating revenue of 1.677 billion yuan for 2025, an increase of 14.95% year-on-year, with a net profit of 311 million yuan, up 23.48% year-on-year [1] - China Shenhua's subsidiary, Guoneng Qingyuan Power, successfully put its fourth generator unit into commercial operation, expected to provide approximately 20 billion kWh of clean energy annually [2] - Qijiang Airlines announced a 6.04% year-on-year decline in passenger turnover for January 2026, with a passenger load factor of 84.03%, up 1.61% year-on-year [3] Group 2 - QiZheng Tibetan Medicine reported a total operating revenue of 2.416 billion yuan for 2025, a year-on-year increase of 3.34%, with a net profit of 646 million yuan, up 10.98% year-on-year [5] - QiaoYin Co. announced the termination of its artificial intelligence industry headquarters project due to changes in investment cooperation conditions [6] - New Point Software plans to use 90.81 million yuan of surplus raised funds for new projects, including AI-driven software development [7] Group 3 - High Measurement Co. announced plans for major shareholders and executives to reduce their holdings by up to 3.19% of the company's shares [8] - SAIC Group's subsidiary plans to establish a private equity fund with an initial scale of 2.5 billion yuan, focusing on solid-state batteries and chip localization [9] - Tianqi Lithium announced the resignation of its deputy general manager due to personal career planning [10] Group 4 - ZhongKong Technology reported a total operating revenue of 8.051 billion yuan for 2025, a decrease of 11.90%, with a net profit of 450 million yuan, down 59.70% year-on-year [11] - Spring Airlines reported a 6.28% year-on-year increase in total passenger volume for January 2026, with a total available ton-kilometers of 57,008.37 [12] - Qifan Cable's controlling shareholder reduced its stake by 3% through various trading methods [13] Group 5 - China Chemical signed contracts worth a total of 36.925 billion yuan in January 2026, with significant contracts exceeding 5 billion yuan totaling 11.371 billion yuan [19] - SaiTuo Bio received a CEP certificate for its raw material drug Betamethasone, which is used to treat allergies and autoimmune inflammation [20] - Giant Star Agriculture reported a sales revenue of 649 million yuan from commodity fat pigs in January 2026, with a sales volume of 404,400 pigs [23] Group 6 - Qinglong Pipe Industry's subsidiary won a 146 million yuan pipeline project [24] - Changshan Pharmaceutical announced that some of its products are expected to be selected for national centralized procurement [26] - Yangdian Technology completed the transfer of 12.96% of its shares through an agreement [27] Group 7 - Deepin Technology's investment fund introduced new limited partners and adjusted the capital contributions of some partners [28] - Qingyun Technology plans to pledge 25% of its shares for a loan application of up to 30 million yuan [29] - LaiMei Pharmaceutical reported a 57.20% year-on-year decline in net profit for 2025 [30] Group 8 - YouLiDe reported a 16.88% year-on-year decline in net profit for 2025, with total operating revenue of 1.221 billion yuan, up 7.99% [31] - Warner Pharmaceutical reported a net profit of 241 million yuan for 2025, an increase of 46.95% year-on-year [32] - LianRui New Materials reported a net profit of 293 million yuan for 2025, an increase of 16.42% year-on-year [33] Group 9 - HuaQin Technology expects a 24.28% year-on-year decrease in net profit for 2025, with projected revenue of 1.251 billion yuan, up 9.83% [34] - QiPai Technology's shareholder subscribed for 6.3 million shares, accounting for 5.49% of the total share capital [35] - Qilin Security's shareholders completed their planned share reductions without exceeding the original plan [36] Group 10 - Dameng Data announced the lifting of the detention of its senior vice president, allowing him to resume his duties [37] - Haiyou Engineering won a contract for the "NFPS COMP5" project worth approximately 4 billion USD, with the company's share exceeding 800 million USD [38] - Yatai Group plans to sell 20.81% of its shares in Northeast Securities, pending confirmation of financial statements [39]

Core Viewpoint - Huajin Technology (688281.SH) reported a revenue of 1.251 billion yuan for the year 2025, reflecting a year-on-year growth of 9.83%, while the net profit attributable to the parent company decreased by 24.28% to 313 million yuan [1] Group 1 - The company is in a critical phase of product updates for its special functional materials, with an increasing proportion of revenue coming from trial-produced products [1] - The new model products have not yet achieved mass production due to factors such as process optimization, new production line debugging, and yield ramp-up, leading to higher trial production costs [1] - The price difference adjustment between some special functional materials and the final approved price has also impacted the company's revenue and profit for the year 2025 [1]

华秦科技(688281.SH)披露2025年度业绩快报，2025年实现营业收入12.51亿元，同比增长9.83%;实现归 属于母公司所有者的净利润3.13亿元，同比减少24.28%。 公司本部特种功能材料等产品正处于产品更新换代的关键阶段，跟研试制产品收入占比逐步提高，但由 于尚未定型批产，受工艺路线优化、新建产线调试及良品率爬坡等因素影响，新型号产品暂未实现规模 化生产，试制成本较高;公司本部部分特种功能材料产品暂定价与最终批复价的价差调整对2025年度收 入及利润亦产生部分影响。 ...

格隆汇2月13日丨华秦科技(688281.SH)公布2025年度业绩快报，报告期内，公司预计实现营业收入12.51 亿元，同比增长9.83%；公司预计实现归属于母公司所有者的净利润3.13亿元，同比减少24.28%；预计 实现归属于母公司所有者扣除非经常性损益后的净利润为2.70亿元，同比减少30.47%。 (2)公司2025年度研发投入约1.46亿元，较2024年度增长约59.65%，随着研发人员增加以及跟研项目较 多，研发材料消耗、研发人力成本、外部协作费用及实验测试支出均呈现显著增长。公司2025年度研发 投入加大，短期内将对盈利水平产生一定影响，但上述投入将有效巩固公司的技术壁垒，为长期可持续 发展构建坚实的核心竞争力基础。 (3)子公司目前处于市场拓展及产能利用率爬坡阶段，整体投入与当期收益暂时不匹配，在此期间，建 设期资本化支出、试运行成本及未达产产线的运营成本较高，对整体盈利水平造成阶段性压力。 (1)公司本部特种功能材料等产品正处于产品更新换代的关键阶段，跟研试制产品收入占比逐步提高， 但由于尚未定型批产，受工艺路线优化、新建产线调试及良品率爬坡等因素影响，新型号产品暂未实现 规模化生产，试制 ...

证券代码：688281 证券简称：华秦科技 公告编号：2026-007 陕西华秦科技实业股份有限公司 2025 年度业绩快报公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 本公告所载 2025 年度主要财务数据为陕西华秦科技实业股份有限公司（以 下简称"公司"）初步核算数据，未经会计师事务所审计，具体数据以公司 2025 年年度报告中披露的数据为准，提请投资者注意投资风险。 | | | | 单位：万元 | | --- | --- | --- | --- | | 项目 | 本报告期 | 上年同期 | 增减变动幅度（%） | | 营业总收入 | 125,121.97 | 113,924.53 | 9.83 | | 营业利润 | 30,210.95 | 44,427.99 | -32.00 | | 利润总额 | 31,107.65 | 44,178.61 | -29.59 | | 归属于母公司所有者的净利润 | 31,343.58 | 41,392.24 | -24.28 | | 归属于母公司所有者的扣除非 经常性损益的净 ...

Core Viewpoint - The company, Huayin Technology (688281.SH), reported its 2025 performance forecast, indicating a revenue increase but a significant decline in net profit due to various operational challenges and increased R&D investments [1][2]. Group 1: Financial Performance - The company expects to achieve an operating revenue of 1.251 billion yuan, representing a year-on-year growth of 9.83% [1] - The net profit attributable to the parent company is projected to be 313 million yuan, a decrease of 24.28% year-on-year [1] - The net profit after deducting non-recurring gains and losses is estimated at 270 million yuan, down 30.47% year-on-year [1] Group 2: Operational Challenges - The company is undergoing a critical phase of product updates for its special functional materials, with a rising proportion of revenue from research and trial products, but these new models have not yet achieved mass production, leading to high trial costs [1] - The pricing adjustments for certain special functional materials have also impacted the revenue and profit for 2025 [1] Group 3: R&D Investments - The company plans to invest approximately 146 million yuan in R&D for 2025, an increase of about 59.65% compared to 2024, driven by a rise in R&D personnel and numerous ongoing projects [1] - The significant increase in R&D expenditures, including material consumption, labor costs, external collaboration fees, and testing expenses, is expected to exert short-term pressure on profitability [1] - However, these investments are aimed at strengthening the company's technological barriers and establishing a solid foundation for sustainable long-term development [1]

Core Insights - The report indicates a cautiously optimistic outlook for February, with the index expected to remain stable and oscillate around the high and low points of January, suggesting a controlled approach to position management during the holiday season [3][8] - The mid-cap blue-chip style is expected to continue, with a focus on adjusting positions rather than passive defense, particularly in the livestock and chemical sectors [3][8] Market Strategy - The index is showing a slightly strong oscillation, with market sentiment indicating a lower risk appetite compared to the previous week, leading to rapid sector rotations [3][8] - Recommendations include controlling positions to avoid uncertainties during the holiday while being prepared for potential liquidity recovery post-holiday [3][8] Industry Strategy - In the agriculture sector, pig inventory is at a low point, with price bottoms being tested ahead of the holiday, indicating a potential recovery in market sentiment regarding pig prices [5][8] - The report highlights that the average weight of pigs post-slaughter has dropped to approximately 88.3 kg, suggesting limited downside for pig prices, with expectations for a price turning point in Q2 2026 [5][8] Thematic Strategy - The military industry is highlighted for its potential due to the resonance of domestic and international demand, with significant growth opportunities anticipated in unmanned and deep-sea technologies, as well as in military trade markets [6][8] - The report emphasizes the importance of the "14th Five-Year Plan" for the military sector, which is expected to clarify new equipment construction plans and enhance investment opportunities [6][8]